UNSPSC 51285606: Lasalocid a

This classification denotes an antibiotic with the molecular formula C34H54O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W7V2ZZ2FWB, chemically known as 2,3-cresotic acid, 6-(7-(5-ethyl-5-(5-ethyltetrahydro-5-hydroxy-6-methyl-2h-pyra but more generally known as lasalocid, which bears US NIH Compound Identifier 3888. European Medicines Agency schedules Lasalocid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08406MIG.

UNSPSC 51285606 Lasalocid a is a Commodity code covering pharmaceutical active ingredients and compounds used in animal health, veterinary medicine, and related applications. Recent state and local procurement under this code shows minimal relevant activity; the opportunities posted do not align with the code's nominal scope. The Illinois Department of Public Health's August 2026 piggyback award through MMCAP Infuse to Chartwell Rx LLC covered Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets — broad-spectrum antibiotics for human use, not lasalocid — for $2,999,999.11 over three contract years. Seminole County, Florida's June 2026 IFB solicitation sought Naloxone and Safe Drug Deactivation Systems for community health, also outside the code's intended scope. Both opportunities involve pharmaceutical procurement through state and local health agencies, but neither addresses lasalocid or animal-health compounds.

The code shows little current state and local procurement activity aligned with its actual product category. Illinois Department of Public Health and Seminole County are the only recent issuing bodies visible in the opportunities block, and their solicitations reflect emergency medical supplies and antimicrobial procurement rather than livestock feed additives or veterinary pharmaceuticals. Without additional opportunities tagged to this code from state and local solicitation platforms, the market activity remains opaque. Firms pursuing lasalocid or similar active pharmaceutical ingredients in the animal-health sector should monitor state agricultural departments, state veterinary boards, and cooperative purchasing consortia for future activity, as the current opportunity stream does not support a clear procurement pattern.